BeOne Medicines beats top-line and bottom-line estimates; updates FY guidance

19 hours ago 1

Earnings News

BeOne Medicines press release (NASDAQ:ONC): Q2 Non-GAAP EPADS of $2.25 beats by $1.99.
Revenue of $1.32B (+42.1% Y/Y) beats by $80M.
Global BRUKINSA revenues increased 49% to $950 million versus second quarter 2024.
Free Cash Flow for the second quarter of

Recommended For You

More Trending News

Read Entire Article